Relationship of in vitro hydrolysis of 17-chloroacetylajmaline and 17-acetylajmaline in different animal species.

Journal of Pharmaceutical Sciences
M SalmonaE Mussini

Abstract

17-Chloroacetylajmaline and 17-acetylajmaline are reported to have in vivo antiarrhythmic activity and are metabolized by hydrolysis. Since the hydrolysis product, ajmaline, may be the actual antiarrhythmic agent, the hydrolysis of these derivatives by various tissues of the guinea pig, rat, and mouse was determined in vitro by a titrimetric method and compared to hydrolysis by alpha-naphthylacetate. The heart is the most active tissue in the guinea pig for hydrolyzing 17-chloroacetylajmaline. The hydrolyzing activity is greater in the guinea pig than in rat or mouse heart, corresponding with the more significant pharmacological activity in the guinea pig. 17-Chloroacetylajmaline has a significantly lower Km value than 17-acetylajmaline, which is in agreement with the in vivo activity.

References

Jul 6, 1971·Annals of the New York Academy of Sciences·B La Du
Apr 1, 1969·Biochemical Pharmacology·W S Schwark, D J Ecobichon
Feb 1, 1966·The American Journal of Cardiology·V BazikaE Corday
Apr 1, 1967·Canadian Journal of Biochemistry·W S Schwark, D J Ecobichon
Jul 1, 1967·Canadian Journal of Biochemistry·D J Ecobichon, Y Israel
Jul 1, 1962·Biochemical Pharmacology·D J ECOBICHON, W KALOW

❮ Previous
Next ❯

Citations

Jan 1, 1979·European Journal of Drug Metabolism and Pharmacokinetics·F CrespiE Mussini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.